All NICE products on haemorrhoids and other anal conditions. Includes any guidance and advice.
Evidence-based recommendations on stapled haemorrhoidopexy for treating haemorrhoids
Evidence-based recommendations on radiofrequency treatment for haemorrhoids in adults
Evidence-based recommendations on electrotherapy for treating haemorrhoids
Evidence-based recommendations on superior rectal artery embolisation for haemorrhoids in adults
Everything NICE has said on gastrointestinal conditions in an interactive flowchart
Advice on the use of eXroid, using direct current electrotherapy to blood vessels of internal haemorrhoid to shrink haemorrhoids, to aid local decision making
Evidence-based recommendations on haemorrhoidal artery ligation for treating haemorrhoids (piles)
Evidence-based recommendations on circular stapled haemorrhoidectomy for treating internal haemorrhoids
This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis.
Guidance, advice and information services for health, public health and social care professionals.
The complete list of medtech innovation briefings published by NICE.
Question Further research in superior rectal artery embolisation for haemorrhoids should report details of patient selection, and...
This guideline covers the care that healthy women and their babies should be offered during pregnancy. It aims to ensure that pregnant women are offered regular check-ups, information and support.
NICE encourages further research into radiofrequency treatment for haemorrhoids, preferably randomised controlled trials. It may update...
This guideline covers the routine postnatal care women and their babies should receive for 6–8 weeks after the birth. It includes advice given on breastfeeding, and the management of common and serious health problems in women and their babies after the birth.
NICE technology appraisal guidance static list
This quality standard covers managing faecal (bowel) incontinence in adults (aged 18 and over) in the community (at home and in care homes) and in all hospital departments. It includes assessment of bowel control problems, advice and support, and treatment options. It describes high-quality care in priority areas for improvement.
Summary of the evidence on botulinum toxin type A injection for treating chronic anal fissure to inform local NHS planning and decision-making
Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart
This medtech innovation briefing is temporarily unavailable, please contact mibs@nice.org.uk for further information.
| NICE encourages further research into radiofrequency treatment for haemorrhoids, preferably randomised controlled trials. It may...